Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient

J Infect. 2020 Sep;81(3):e31-e32. doi: 10.1016/j.jinf.2020.06.076. Epub 2020 Jul 2.

Abstract

We followed-up a mild COVID-19 patient for 91 days and serially monitored his serum antibodies to four SARS-CoV-2 related antigens (NP, RBD, S1 and ECD) and neutralization activities. Our data revealed a profile of serial antibody responses during the progress and a quick decline of neutralization activities after discharge.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Neutralizing / immunology*
  • Antibodies, Viral / immunology*
  • Antigens, Viral / immunology
  • Betacoronavirus / immunology*
  • COVID-19
  • Coronavirus Infections / immunology*
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Longitudinal Studies
  • Male
  • Neutralization Tests
  • Pandemics
  • Pneumonia, Viral / immunology*
  • RNA, Viral
  • Retrospective Studies
  • SARS-CoV-2

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Antigens, Viral
  • RNA, Viral